CEREBRAL GLUCOSE-METABOLISM IN NEUROFIBROMATOSIS TYPE-1 ASSESSED WITH [F-18] 2-FLUORO-2-DEOXY-D-GLUCOSE AND PET

被引:23
作者
BALESTRI, P [1 ]
LUCIGNANI, G [1 ]
FOIS, A [1 ]
MAGLIANI, L [1 ]
CALISTRI, L [1 ]
GRANA, C [1 ]
DIBARTOLO, RM [1 ]
PERANI, D [1 ]
FAZIO, F [1 ]
机构
[1] UNIV MILAN, INST HS RAFFAELE, CNR, INB, MILAN, ITALY
关键词
D O I
10.1136/jnnp.57.12.1479
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebral PET with [F-13]-2-fluoro-2-deoxy-D-glucose has been performed in four patients with neurofibromatosis type 1 (NF1) to assess the relation between cerebral metabolic activity, MRI, and the presence of neurological symptoms, including seizures, as well as mental and language retardation. Widespread hypometabolism occurred in three of the patients. The lesions on MRI, which were localised in the subcortical white matter and grey structures, had normal rates of glucose metabolism. This finding suggests that the abnormalities seen on MRI are not due to defective blood supply, localised oedema, or grey matter heterotopic foci as previously hypothesised. The presence of the hypometabolic areas seems to be inconsistently related to the occurrence of seizures and is not proportional to the degree of mental impairment. This study provides evidence of a widespread cerebral hypometabolism that is not related to the presence of MRI abnormalities; conversely normal metabolism was present in the areas with an abnormal MRI signal.
引用
收藏
页码:1479 / 1483
页数:5
相关论文
共 30 条
[21]   CENTRAL NERVOUS SYSTEM PATHOLOGY IN MULTIPLE NEUROFIBROMATOSIS [J].
PEARCE, J .
NEUROLOGY, 1967, 17 (07) :691-&
[22]   GLUCOSE METABOLIC-RATE KINETIC-MODEL PARAMETER DETERMINATION IN HUMANS - THE LUMPED CONSTANTS AND RATE CONSTANTS FOR [F-18] FLUORODEOXYGLUCOSE AND [C-11] DEOXYGLUCOSE [J].
REIVICH, M ;
ALAVI, A ;
WOLF, A ;
FOWLER, J ;
RUSSELL, J ;
ARNETT, C ;
MACGREGOR, RR ;
SHIUE, CY ;
ATKINS, H ;
ANAND, A ;
DANN, R ;
GREENBERG, JH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1985, 5 (02) :179-192
[23]  
RICCARDI V M, 1989, Neurofibromatosis, V2, P284
[24]  
Riccardi V.M., 1987, NEUROCUTANEOUS DISEA, P11
[25]  
RUBINSTEIN AE, 1981, ADV NEUROL, V29, P11
[26]  
SAMUELSSON B, 1989, Neurofibromatosis, V2, P78
[27]  
SCHORRY EK, 1988, NEUROFIBROMATOSIS RE, V4, P8
[28]   [DEOXYGLUCOSE-C-14 METHOD FOR MEASUREMENT OF LOCAL CEREBRAL GLUCOSE-UTILIZATION - THEORY, PROCEDURE, AND NORMAL VALUES IN CONSCIOUS AND ANESTHETIZED ALBINO-RAT [J].
SOKOLOFF, L ;
REIVICH, M ;
KENNEDY, C ;
DESROSIERS, MH ;
PATLAK, CS ;
PETTIGREW, KD ;
SAKURADA, O ;
SHINOHARA, M .
JOURNAL OF NEUROCHEMISTRY, 1977, 28 (05) :897-916
[29]   EFFECT OF PHENYTOIN ON HUMAN CEREBRAL GLUCOSE-METABOLISM [J].
THEODORE, WH ;
BAIRAMIAN, D ;
NEWMARK, ME ;
DICHIRO, G ;
PORTER, RJ ;
LARSON, S ;
FISHBEIN, D .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (03) :315-320
[30]  
ZIMMERMAN RA, 1992, RADIOLOGY, V185, P123